These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3055991)

  • 1. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis.
    Keane WF; Kasiske BL; O'Donnell MP
    Am J Nephrol; 1988; 8(4):261-71. PubMed ID: 3055991
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
    Krämer-Guth A; Nauck M; Pavenstädt H; Königer M; Wieland H; Schollmeyer P; Wanner C
    J Am Soc Nephrol; 1994 Oct; 5(4):1081-90. PubMed ID: 7849247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal lipid metabolism in nephrotic syndrome].
    Mizobata R; Mune M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():152-5. PubMed ID: 11347048
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of lipids in progressive glomerular disease.
    Keane WF; Kasiske BL; O'Donnell MP
    Adv Exp Med Biol; 1987; 223():81-7. PubMed ID: 3447453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids and progressive renal injury.
    Schmitz PG; Kasiske BL; O'Donnell MP; Keane WF
    Semin Nephrol; 1989 Dec; 9(4):354-69. PubMed ID: 2688011
    [No Abstract]   [Full Text] [Related]  

  • 6. Focal glomerular sclerosis and nephrotic syndrome with partial lecithin:cholesterol acetyltransferase deficiency and discoidal high density lipoprotein in plasma and urine.
    Moorhead JF; El-Nahas M; Harry D; Persaud JW; Mayne K; Chan MK; Varghese Z
    Lancet; 1983 Apr; 1(8330):936-7. PubMed ID: 6132255
    [No Abstract]   [Full Text] [Related]  

  • 7. Atherosclerosis and glomerulosclerosis in WHHL rabbits and obese Zucker rats.
    Shimamura T; Amorosa LF; Wilson AC; Lelkes L; Khachadurian AK
    Jpn J Exp Med; 1990 Jun; 60(3):105-9. PubMed ID: 2214254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models of glomerulosclerosis.
    Weening JJ; Westenend PJ; Beukers JJ; Grond J
    Contrib Nephrol; 1990; 77():65-76. PubMed ID: 2344746
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular lipid metabolism and the role of lipids in progressive renal disease.
    Abrass CK
    Am J Nephrol; 2004; 24(1):46-53. PubMed ID: 14707435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraglomerular lipid deposition in experimental focal glomerular sclerosis in the rat.
    Ohsawa H; Yamabe H; Ozawa K; Fukushi K; Kubota H; Chiba N; Sohma Y; Kanazawa T; Onodera K
    Nephron; 1988; 50(1):66. PubMed ID: 3173607
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T; Morohoshi T
    Nephron; 1992; 60(4):443-7. PubMed ID: 1584321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome.
    Kees-Folts D; Diamond JR
    Am J Nephrol; 1993; 13(5):365-75. PubMed ID: 8116689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors, atherosclerosis and thromboembolism in the nephrotic syndrome].
    Previato G; Loschiavo C; Tessitore N; Chiaramonte S; Oldrizzi L; Lupo A; Valvo E; Maschio G; Saporiti E
    Minerva Nefrol; 1981; 28(3):421-30. PubMed ID: 7036020
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of lipids in the pathogenesis of glomerulosclerosis in the rat following subtotal nephrectomy.
    Rayner HC; Ross-Gilbertson VL; Walls J
    Eur J Clin Invest; 1990 Feb; 20(1):97-104. PubMed ID: 2108041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, endothelial cell turnover and lipid transport in atherogenesis.
    Lin SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):309-16. PubMed ID: 9037845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal glomerular sclerosis in non-nephrotic patients with hyperlipidemia.
    Saito T; Sato H; Akiu N; Ootaka T; Furuyama T; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1987 Sep; 29(9):1107-14. PubMed ID: 3694889
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidemia and the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP
    Am J Clin Nutr; 1988 Jan; 47(1):157-60. PubMed ID: 3276133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis.
    Gröne HJ; Walli AK; Gröne EF
    Clin Investig; 1993 Oct; 71(10):834-9. PubMed ID: 8305844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of glomerulosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Westenend PJ; Kroon AA; Stalenhoef AF; Assmann KH
    Nephron; 1993; 64(1):150-1. PubMed ID: 8502322
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue lipoprotein lipase, serum, and urinary lipids and lipoproteins in experimental glomerulonephritis of rats (Heymann's nephritis).
    Van Zoeren D; Adams LE; Hynd BA; Hess EV; Kashyap ML
    Biochem Med; 1981 Jun; 25(3):260-6. PubMed ID: 7271761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.